Published in Community Health Stud on January 01, 1989
Hypoxia induces the expression of the pro-apoptotic gene BNIP3. Cell Death Differ (2001) 2.01
Effect of phospholipase C-gamma overexpression on PDGF-induced second messengers and mitogenesis. Science (1990) 1.87
Stimulation of healing of varicose ulcers by ultrasound. Ultrasonics (1976) 1.22
hUBC9 associates with MEKK1 and type I TNF-alpha receptor and stimulates NFkappaB activity. FEBS Lett (1998) 0.95
Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Exp Cell Res (1998) 0.90
Local immunotherapy of recurrent glioblastoma multiforme by intracerebral perfusion of interleukin-2 and LAK cells. Eur Cytokine Netw (1994) 0.85
Endothelin receptor antagonists are an effective long term treatment option in pulmonary arterial hypertension associated with congenital heart disease with or without trisomy 21. Heart Lung Circ (2010) 0.82
In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses. Br J Cancer (1994) 0.80
Interleukin-2 therapy for refractory and relapsing lymphomas. Eur J Cancer (1991) 0.77
Cloning and characterization of human Jak-2 kinase: high mRNA expression in immune cells and muscle tissue. Biochem Biophys Res Commun (1998) 0.76
Clinical status of carboplatin. Oncology (Williston Park) (1987) 0.75
Lymphokine-activated killer cell expansion for clinical trials of adoptive immunotherapy with interleukin-2: optimization of the culture technique. Mol Biother (1990) 0.75
Chemical carcinogen Epstein-Barr virus (EBV) synergism: EBV genome amplification and site-specific mutation during transformation. Int J Cancer (1989) 0.75
Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient. Pediatr Emerg Care (1995) 0.75
Possible community immunity to small round structured virus gastroenteritis in a rural aboriginal community. Commun Dis Intell (2000) 0.75
Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual disease. Nouv Rev Fr Hematol (1990) 0.75
Immune reconstitution after bone-marrow transplantation. Cancer Treat Rev (1989) 0.75
A phase II study of tamoxifen combined with cisplatin-interleukin 2 and alpha-interferon in metastatic melanoma. Am J Clin Oncol (1995) 0.75
Chemoimmunotherapy of metastatic malignant melanoma. The Salpétrière Hospital (SOMPS) experience. Eur J Cancer (1993) 0.75